A Phase Ib Study of Rapamycin (Sirolimus) in Patients With Advanced Malignancies
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2012
At a glance
- Drugs Sirolimus (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2008 New trial record.